Literature DB >> 17598973

Goiter rate, serum thyrotropin, thyroid autoantibodies and urinary iodine concentration in Tehranian adults before and after national salt iodization.

P Heydarian1, A Ordookhani, F Azizi.   

Abstract

Goiter rate, serum TSH, antithyroperoxidase (TPOAb), antithyroglobulin (TgAb) antibodies, and urinary iodine concentration (UIC) were evaluated 10-11 yr prior (1983-1984) and 5-6 yr after (1999-2000) national salt iodization in Iran. Pre- and post-iodization groups consisted of 465 and 1426 adults aged > or =20 yr, respectively, selected by random cluster sampling in Tehran province. Total, grade 1 and grade 2 goiter rates were 65.2, 53.1, and 12.1% in 1983-1984 vs 25.2, 15.5, and 9.7% in 1999-2000 (p<0.0001). Median serum TSH was 1.5 mIU/l in 1983-1984 vs 0.8 mIU/l in 1999-2000 (p<0.0001). Median TSH also decreased in 20-29, 30-39, 40-49, 50-59, and > or =60- yr-adults in 1983-1984 vs 1999-2000 (p<0.0001). In 1983-1984, positive TPOAb and positive TgAb were detected in 3.2 and 4%, respectively, using agglutination test. Corresponding values were 12.5 and 16.8% using immunoenzymometric assay in 1999-2000. Overt and subclinical hypothyroidism was present in 0 and 32.8/1000 in 1983-1984 vs 3.5 and 21.7/1000 in 1999-2000, respectively. Overt and subclinical hyperthyroidism was detected in 4.4 and 4.4/1000 in 1983-1984 vs 0.7 and 5.6/1000 in 1999-2000, respectively. Subclinical hypothyroidism in males was significantly more frequent in 1983-1984 vs 1999-2000 (odds ratio 5.02, 95% confidence interval 1.72-14.68; p=0.004). Salt iodization resulted in adequate UIC, decrease in serum TSH and subclinical hypothyroidism in males, and an increase in thyroid autoantibodies without significant change in thyroid abnormalities. Benefits of iodine supplementation far outweigh its hazards in Tehranian adults.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17598973     DOI: 10.1007/BF03346318

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Reappraisal of the risk of iodine-induced hyperthyroidism: an epidemiological population survey.

Authors:  F Azizi; M Hedayati; M Rahmani; R Sheikholeslam; S Allahverdian; N Salarkia
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

Review 2.  Vascular and platelet eicosanoids, smoking and atherosclerosis.

Authors:  J Y Jeremy; D P Mikhailidis
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

Review 3.  The thyrotropin reference range should remain unchanged.

Authors:  Martin I Surks; Gayotri Goswami; Gilbert H Daniels
Journal:  J Clin Endocrinol Metab       Date:  2005-09       Impact factor: 5.958

4.  Prevalence of thyroid antibodies in Shiraz, Iran, an area with iodine deficiency.

Authors:  A A Khaleeli
Journal:  Postgrad Med J       Date:  1981-01       Impact factor: 2.401

Review 5.  Iodine deficiency in the world: where do we stand at the turn of the century?

Authors:  F Delange; B de Benoist; E Pretell; J T Dunn
Journal:  Thyroid       Date:  2001-05       Impact factor: 6.568

Review 6.  Iodine deficiency as a cause of brain damage.

Authors:  F Delange
Journal:  Postgrad Med J       Date:  2001-04       Impact factor: 2.401

7.  Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study.

Authors:  Peter C O'Leary; Peter H Feddema; Valdo P Michelangeli; Peter J Leedman; Gerard T Chew; Matthew Knuiman; Joey Kaye; John P Walsh
Journal:  Clin Endocrinol (Oxf)       Date:  2006-01       Impact factor: 3.478

8.  Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Ruth M Belin; Brad C Astor; Neil R Powe; Paul W Ladenson
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

9.  Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease.

Authors:  Thea G A Strieder; Mark F Prummel; Jan G P Tijssen; Eric Endert; Wilmar M Wiersinga
Journal:  Clin Endocrinol (Oxf)       Date:  2003-09       Impact factor: 3.478

10.  Eliminating iodine deficiency disorders--the role of the International Council in the global partnership.

Authors:  Basil S Hetzel
Journal:  Bull World Health Organ       Date:  2002       Impact factor: 9.408

View more
  15 in total

Review 1.  The incidence and prevalence of thyroid autoimmunity.

Authors:  Donald S A McLeod; David S Cooper
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

Review 2.  Iodine-induced thyroid dysfunction.

Authors:  Angela M Leung; Lewis E Braverman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-10       Impact factor: 3.243

Review 3.  Global epidemiology of hyperthyroidism and hypothyroidism.

Authors:  Peter N Taylor; Diana Albrecht; Anna Scholz; Gala Gutierrez-Buey; John H Lazarus; Colin M Dayan; Onyebuchi E Okosieme
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

4.  Prevalence of goitre in Isfahan, Iran, fifteen years after initiation of universal salt iodization.

Authors:  Ashraf Aminorroaya; Massoud Amini; Silva Hovsepian
Journal:  J Health Popul Nutr       Date:  2010-08       Impact factor: 2.000

5.  The role of thyroid autoantibodies in the etiology of endemic goiter in schoolchildren of Isfahan, Iran.

Authors:  N Khalili; M Hashemipour; A H Keshteli; M Siavash; M Amini
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

Review 6.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

7.  Incidence of thyroid disorders in the second decade of adequate iodine supply in Slovenia.

Authors:  Simona Gaberšček; Brina Gaberšček; Katja Zaletel
Journal:  Wien Klin Wochenschr       Date:  2020-05-06       Impact factor: 1.704

8.  The incidence of thyroid function abnormalities and natural course of subclinical thyroid disorders, Tehran, I.R. Iran.

Authors:  H Delshad; L Mehran; M Tohidi; M Assadi; F Azizi
Journal:  J Endocrinol Invest       Date:  2011-09-30       Impact factor: 5.467

9.  Ten-year follow-up of thyroid epidemiology in Slovenia after increase in salt iodization.

Authors:  Katja Zaletel; Simona Gaberscek; Edvard Pirnat
Journal:  Croat Med J       Date:  2011-10-15       Impact factor: 1.351

10.  Hashimoto's Thyroiditis: From Genes to the Disease.

Authors:  Katja Zaletel; Simona Gaberšček
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.